Research Chemical Profile
Ultima-NPP 100 is a nandrolone phenylpropionate formulation manufactured by Ultima Pharmaceuticals for analytical research purposes. This anabolic steroid compound belongs to the 19-nortestosterone family and represents a short-acting ester variant of nandrolone. Researchers at Stroid UK Shop examine this compound for its unique pharmacokinetic properties and receptor binding characteristics in controlled laboratory settings. The phenylpropionate ester attachment provides researchers with opportunities to study rapid onset kinetics compared to longer-acting variants. Laboratory investigations focus on understanding the molecular mechanisms underlying nandrolone’s interaction with androgen receptors and its tissue-selective effects. Scientists studying hormonal pathways often examine this compound alongside other research materials available in our nandrolone phenylpropionate collection to understand comparative pharmacology. Advanced research protocols may incorporate this compound with peptide modulators from our peptides range or selective receptor modulators from our SARMs category for comprehensive hormonal pathway analysis.
Laboratory Investigation Applications
Research teams investigate nandrolone phenylpropionate for its distinct biochemical properties in cellular assays and receptor binding studies. The compound demonstrates high affinity for androgen receptors while exhibiting reduced 5α-reductase metabolism compared to testosterone-based compounds. Laboratory analyses focus on understanding the molecular basis for tissue selectivity, particularly in muscle versus prostate tissue models. Researchers examine the compound’s interaction with sex hormone-binding globulin and its effects on nitrogen retention pathways in cellular systems. The phenylpropionate ester undergoes hydrolysis studies to understand release kinetics and active metabolite formation. Comparative investigations assess this variant against nandrolone decanoate to elucidate ester-dependent pharmacological differences. Cell culture studies explore the compound’s influence on protein synthesis markers and myofibrillar protein expression. Advanced research protocols investigate potential applications in muscle wasting disease models and bone density research paradigms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Nandrolone Phenylpropionate |
| Concentration | 100mg/ml |
| Manufacturer | Ultima Pharmaceuticals |
| Formulation | Injectable Solution |
| Chemical Formula | C₂₈H₃₆O₃ |
| Molecular Weight | 420.58 g/mol |
| CAS Number | 62-90-8 |
| Storage Requirements | Room temperature, protected from light |
Research Use Compliance
Ultima-NPP 100 is manufactured exclusively for in-vitro research applications and analytical testing in qualified laboratory facilities. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must possess appropriate licensing and expertise in anabolic steroid chemistry before conducting studies with this compound. All investigations must comply with relevant institutional guidelines and regulatory frameworks governing controlled substance research. Proper laboratory safety protocols, including appropriate personal protective equipment and waste disposal procedures, must be implemented during handling.
